- Home
- TRVI vs EVN Comparison
TRVI vs EVN Comparison
Compare TRVI & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- EVN
- Stock Information
- Founded
- TRVI 2011
- EVN 1998
- Country
- TRVI United States
- EVN United States
- Employees
- TRVI N/A
- EVN N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- EVN Investment Bankers/Brokers/Service
- Sector
- TRVI Health Care
- EVN Finance
- Exchange
- TRVI Nasdaq
- EVN Nasdaq
- Market Cap
- TRVI 383.4M
- EVN 410.0M
- IPO Year
- TRVI 2019
- EVN N/A
- Fundamental
- Price
- TRVI $6.07
- EVN $9.94
- Analyst Decision
- TRVI Strong Buy
- EVN
- Analyst Count
- TRVI 8
- EVN 0
- Target Price
- TRVI $17.56
- EVN N/A
- AVG Volume (30 Days)
- TRVI 1.6M
- EVN 101.2K
- Earning Date
- TRVI 05-06-2025
- EVN 01-01-0001
- Dividend Yield
- TRVI N/A
- EVN 4.78%
- EPS Growth
- TRVI N/A
- EVN N/A
- EPS
- TRVI N/A
- EVN 0.34
- Revenue
- TRVI N/A
- EVN N/A
- Revenue This Year
- TRVI N/A
- EVN N/A
- Revenue Next Year
- TRVI N/A
- EVN N/A
- P/E Ratio
- TRVI N/A
- EVN $29.94
- Revenue Growth
- TRVI N/A
- EVN N/A
- 52 Week Low
- TRVI $2.30
- EVN $8.64
- 52 Week High
- TRVI $7.39
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- TRVI 54.54
- EVN 38.88
- Support Level
- TRVI $4.85
- EVN $9.71
- Resistance Level
- TRVI $6.15
- EVN $10.12
- Average True Range (ATR)
- TRVI 0.50
- EVN 0.23
- MACD
- TRVI -0.04
- EVN -0.01
- Stochastic Oscillator
- TRVI 73.94
- EVN 39.33
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.